Skip to main content
SpringerLink
Log in

Translating Genetic Discoveries to Improvements in Cardiovascular Care: The Path to Personalized Medicine

  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

Research and development has provided us with several solutions to reduce morbidity and mortality of cardiovascular disease. More solutions are anticipated in the areas of clinical medicine, personal handheld devices, and DNA technology that will continue to enhance the era of personalized medicine. Genome-wide association studies have recently identified genetic variants on chromosome 9 (interval 9p21) and chromosome 4 (4q25) that confer increased risk for myocardial infarction and atrial fibrillation, respectively. The regions on these chromosomes containing the SNPs associated with disease contain no known genes - creating a challenge for scientists. Unraveling the code on these chromosomes may reveal a deeper insight into the mechanisms underlying disease and the design of new therapeutics to prevent or slow the progression of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. The Wellcome Trust Case Control Consortium (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, (447). 661–678.

    Article  Google Scholar 

  2. Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998). Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation, 98, 946–952.

    PubMed  CAS  Google Scholar 

  3. Christensen, K., & Murray, J. C. (2007). What genome-wide association studies can do for medicine. The New England Journal of Medicine, 356, 1094–1097.

    Article  PubMed  CAS  Google Scholar 

  4. Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., et al. (2007). Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature, 448, 353–357.

    Article  PubMed  CAS  Google Scholar 

  5. Lloyd-Jones, D. M., Larson, M. G., Beiser, A., & Levy, D. (1999). Lifetime risk of developing coronary heart disease. Lancet, 353, 89–92.

    Article  PubMed  CAS  Google Scholar 

  6. Lloyd-Jones, D. M., Larson, M. G., Leip, E. P., Beiser, A., D’Agostino, R. B., Kannel, W. B., et al. (2002). Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation, 106, 3068–3072.

    Article  PubMed  Google Scholar 

  7. Lloyd-Jones, D. M., Wang, T. J., Leip, E. P., Larson, M. G., Levy, D., Vasan, R. S., et al. (2004). Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation, 110, 1042–1046.

    Article  PubMed  Google Scholar 

  8. McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., et al. (2007). A common allele on chromosome 9 associated with coronary heart disease. Science, 316, 1488–1491.

    Article  PubMed  CAS  Google Scholar 

  9. Rota, M., Hosoda, T., De Angelis, A., Arcarese, M. L., Esposito, G., Rizzi, R., et al. (2007). The young mouse heart is composed of myocytes heterogeneous in age and function. Circulation Research, 101, 387–399.

    Article  PubMed  CAS  Google Scholar 

  10. Seshadri, S., Beiser, A., Kelly-Hayes, M., Kase, C. S., Au, R., Kannel, W. B., et al. (2006). The lifetime risk of stroke: estimates from the Framingham Study. Stroke, 37, 345–350.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lillehei Heart Institute, University of Minnesota, 4 Nils Hasselmo Hall, 321 Church Street, Minneapolis, MN, 55455, USA

    Jennifer L. Hall

Authors
  1. Jennifer L. Hall
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer L. Hall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hall, J.L. Translating Genetic Discoveries to Improvements in Cardiovascular Care: The Path to Personalized Medicine. J. of Cardiovasc. Trans. Res. 1, 37–40 (2008). https://doi.org/10.1007/s12265-008-9010-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-008-9010-8

Keywords

Search

Navigation